Earnings Per Common Share - Computation of EPS (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Numerator
Income (loss) from continuing operations	$ 334,757	$ 513,540	$ 137,728
Noncontrolling interests’ share in continuing operations	(28,748)	(15,975)	(17,851)
Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.	306,009	497,565	119,877
Less: Participating securities’ share in continuing operations	(1,725)	(2,657)	(3,269)
Income (loss) from continuing operations applicable to common shares	304,284	494,908	116,608
Income (loss) from discontinued operations	0	2,884	388,202
Noncontrolling interests’ share in discontinued operations	0	0	(2,539)
Net income (loss) applicable to common shares	304,284	497,792	502,271
Net income (loss) applicable to common shares	$ 304,284	$ 497,792	$ 502,271
Denominator
Basic weighted average shares outstanding (in shares)	547,006,000	538,809,000	538,930,000
Dilutive potential common shares - equity awards (in shares)	269,000	338,000	310,000
Dilutive potential common shares - forward equity agreements (in shares)	0	0	1,000
Diluted (in shares)	547,275,000	539,147,000	539,241,000
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ 0.56	$ 0.92	$ 0.22
Discontinued operations (in dollars per share)	0	0.00	0.71
Net income (loss) applicable to common shares (in dollars per share)	0.56	0.92	0.93
Diluted earnings (loss) per common share
Continuing operations (in dollars per share)	0.56	0.92	0.22
Discontinued operations (in dollars per share)	0	0.00	0.71
Net income (loss) applicable to common shares (in dollars per share)	$ 0.56	$ 0.92	$ 0.93
Outstanding equity awards (in shares)	1,000,000	1,000,000	1,000,000
Antidilutive securities excluded from computation of earnings per share (in shares)	0
Forward sales agreements that have not been settled (in shares)		9,100,000
Forward sales agreements that have been settled (in shares)			9,100,000